glp-1 and satiety drugs are expected to replace insulin to be the best choice for first-line treatment Glucagon-Like Peptide-1 and Hypothalamic Regulation

Delayed access to effective treatment: Perhaps the most overlooked risk is that using unproven products can delay someone from pursuing treatments that actually have clinical evidence behind them

This can create a paradox: total testosterone may stay normal or even rise slightly after weight loss, but the usable free portion falls, resulting in symptoms of low testosteronefatigue, slower recovery, and loss of muscle definition

As the disorder progresses, the feeling of tingling or numbness may become constant and patients may complain of burning pain

Blood work before starting GLP-1 therapy, and again at month 3, identifies micronutrient gaps before shedding worsens

Together, they help restore healthy hair follicle function

Lepock, J